Cardiac Amyloidosis: What Heart Failure Clinicians Need to Know

Educational Activity

Cardiac amyloidosis is a systemic disease characterized by the extracellular deposition of amyloid proteins in the cardiac tissue. This activity will include case studies, updates, and a patient’s perspective on the pathophysiology, diagnosis, current, and emerging therapeutic options, and guideline-directed management of immunoglobulin light chain cardiac amyloidosis and transthyretin amyloidosis.


The goal of this activity is to improve the heart failure clinician’s knowledge of the

diagnosis, evaluation, and treatment selection.


This educational activity is intended for Physicians, Nurses, Nurse Practitioners, Pharmacists, Scientists, and Health Care Professionals who specialize or have an interest in heart failure.


This activity is supported by unrestricted Educational Partner Accredited Sponsor educational grants provided by the Amyloidosis Research Consortium, Eidos Therapeutics, Ionis Pharmaceuticals, and Pfizer.


Original recording Date: September 11, 2021








Upon completion of the activity, participants will demonstrate improved competence and ability to:


  • Define the two most common forms of cardiac amyloidosis in terms of epidemiology, genetics, prognosis, and treatments
  • Discuss the emerging treatment options for cardiac amyloidosis
  • Review guideline-directed medical therapy and medical management of cardiac amyloidosis and relevant cardiovascular manifestations

Accreditation Statement


In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


The Heart Failure Society of America designates this enduring educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Learners should claim only the credit commensurate with the extent of their participation in the activity.


Credits Available


Powered by Oasis.